chemical entities, pharmaceutical compositions, pharmaceutically acceptable compounds or salts thereof, uses of chemical entities or compositions and methods for treating diseases, disorders or medical conditions mediated by pde1 enzymatic activity and for modulating pde1 enzyme activity

摘要

"Chemical entities, pharmaceutical compositions, pharmaceutically acceptable compounds or salts thereof, uses of chemical entities or compositions and methods for treating diseases, disorders or medical conditions mediated by pde1 enzyme activity and for modulating pde1 enzyme activity" summary are described herein compounds and chemical entities of formula (I), methods of synthesizing them, compositions comprising them and their use in the treatment of various diseases and disorders, including cognitive deficits associated with snc diseases and disorders. 1/1